Ganglioside AGF2 prevents the cognitive impairments and cholinergic cell loss following intraventricular colchicine

Abstract

Ganglioside AGF2 prevented the cognitive and locomotor alterations induced by intraventricular colchicine. Adult male rats were initially trained to perform a standard radial arm maze (RAM) task. Following training, they were injected intraperitoneally with 10 mg/kg AGF2 ( COL AGF2 ), cerebrospinal fluid ( CSF) AGF2 ) or the saline vehicle ( COL SAL , CSF SAL ) for 3 days prior to and for 14 days following the bilateral injection of colchicine ( 7 μ g 0.5 μ l ) or artificial CSF into the lateral ventricles. Colchicine ( COL SAL ) impaired performance of the standard RAM task as well as a working memory version of the task in which various delays were imposed between the fourth and fifth arm choices. Colchicine also produced a transient hyperactivity which subsided within 10 weeks following surgery. In contrast, AGF2 ( COL AGF2 ) prevented the impairments in RAM performance and the alterations in locomotor behavior. Colchicine also produced significant decreases in hippocampal ChAT activity and high affinity choline uptake that were prevented by prior treatment with AGF2. Finally, colchicine produced a 35% decrease in the number of acetylcholinesterase-positive (cholinergic) neurons in the medial septum and vertical limb of the diagonal band ( MS VLDB ) which was also prevented by AGF2. Thus, the behavioral and neurochemical protection afforded by AGF2 was paralleled by a prevention of the loss of hippocampal cholinergic parameters and cholinergic neurons in the MS VLDB .